Digitisation | April 11, 2022
Intuitive launches My Intuitive App
The app serves as a single, integrated, personalized customer platform for da Vinci surgeons
The app serves as a single, integrated, personalized customer platform for da Vinci surgeons
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
Veeda Clinical Research will submit data in an application for Emergency Use Authorisation
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
About 96% of all 15+ population in the country have received at least one Covid-19 vaccine dose while about 83% of 15+ population has received both the doses
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation
Subscribe To Our Newsletter & Stay Updated
